CompletedPHASE2, PHASE3NCT01336660
A Trial of Equine F (ab')2 Antivenom for Treatment of Scorpion Envenomation in Morocco
Studying Scorpion envenomation
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Instituto Bioclon S.A. de C.V.
- Principal Investigator
- Walter Garcia, MDInstituto Bioclon
- Intervention
- Equine F(ab')2 antivenom(biological)
- Enrollment
- 56 target
- Eligibility
- 15 years · All sexes
- Timeline
- 2018 – 2018
Study locations (2)
- CHU Hassan II de Fès, Fes, Morocco
- Hôpital Ibn Zohr, Marrakech, Marrakesh, Morocco
Collaborators
Centre Antipoison et de Pharmacovigilane du Maroc · Institut Pasteur du Maroc
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01336660 on ClinicalTrials.gov